341 related articles for article (PubMed ID: 21800293)
1. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
[TBL] [Abstract][Full Text] [Related]
2. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
[TBL] [Abstract][Full Text] [Related]
3. Metformin and survival in diabetic patients with breast cancer.
El-Benhawy SA; El-Sheredy HG
J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
[TBL] [Abstract][Full Text] [Related]
4. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
[TBL] [Abstract][Full Text] [Related]
6. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
[TBL] [Abstract][Full Text] [Related]
8. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
11. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Jiralerspong S; Palla SL; Giordano SH; Meric-Bernstam F; Liedtke C; Barnett CM; Hsu L; Hung MC; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2009 Jul; 27(20):3297-302. PubMed ID: 19487376
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
13. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
14. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
15. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
Bo S; Benso A; Durazzo M; Ghigo E
J Endocrinol Invest; 2012 Feb; 35(2):231-5. PubMed ID: 22490993
[TBL] [Abstract][Full Text] [Related]
16. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
[TBL] [Abstract][Full Text] [Related]
17. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Hui T; Shang C; Yang L; Wang M; Li R; Song Z
Sci Rep; 2021 May; 11(1):10034. PubMed ID: 33976288
[TBL] [Abstract][Full Text] [Related]
18. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
19. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
[TBL] [Abstract][Full Text] [Related]
20. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.
Wu W; Merriman K; Nabaah A; Seval N; Seval D; Lin H; Wang M; Qazilbash MH; Baladandayuthapani V; Berry D; Orlowski RZ; Lee MH; Yeung SC
Br J Cancer; 2014 Jul; 111(3):628-36. PubMed ID: 24921909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
